Have your own idea? Try our Stock Screener
UPDATED Jan 02, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
4519 | JP¥6,999.00 | -1.5% | 29.9% | JP¥11.5t | JP¥7,416.67 | PE29.8x | E6.3% | 1.2% | ||
ZTS | US$162.61 | -1.8% | -16.2% | US$73.5b | US$213.01 | PE30.2x | E10.0% | 1.2% | ||
REGN | US$715.19 | -0.2% | -21.6% | US$76.6b | US$1,053.08 | PE16.5x | E9.2% | n/a | ||
CSL | AU$281.18 | 0.2% | -1.9% | AU$136.3b | AU$340.56 | PE32x | E13.0% | 1.5% | ||
VRTX | US$405.76 | -1.2% | -2.5% | US$103.7b | US$493.61 | PS9.8x | E36.8% | n/a | ||
BMY | US$56.79 | -2.1% | 9.1% | US$114.7b | US$60.91 | PS2.4x | E37.0% | 4.4% | ||
GILD | US$91.88 | -2.7% | 8.8% | US$115.1b | US$98.92 | PE908.8x | E31.1% | 3.4% | ||
SAN | €94.32 | 2.8% | 1.6% | €118.2b | €113.80 | PE26.2x | E14.8% | 4.0% | ||
AMGN | US$259.28 | -1.5% | -14.5% | US$140.1b | US$321.12 | PE32.9x | E15.9% | 3.7% | ||
PFE | US$26.61 | 0.2% | -8.5% | US$150.3b | US$31.86 | PE35.3x | E9.5% | 6.5% | ||
DHR | US$229.81 | -0.6% | -1.2% | US$165.8b | US$287.31 | PE42.2x | E13.4% | 0.5% | ||
NOVN | CHF 88.70 | 1.2% | -1.3% | CHF 177.3b | CHF 104.40 | PE16.6x | E7.1% | 3.7% | ||
TMO | US$522.57 | -0.9% | -2.8% | US$199.0b | US$648.60 | PE32.6x | E11.5% | 0.3% | ||
AZN | UK£106.30 | 1.9% | -2.2% | UK£164.8b | UK£139.39 | PE31.4x | E16.9% | 2.2% | ||
ROG | CHF 255.50 | 1.8% | 0.5% | CHF 205.2b | CHF 303.36 | PE19.2x | E10.5% | 3.8% | ||
MRK | US$99.17 | -0.7% | -15.2% | US$251.6b | US$128.73 | PE20.7x | E12.2% | 3.3% | ||
ABBV | US$179.44 | 0.1% | 11.1% | US$314.0b | US$202.54 | PE62.4x | E23.7% | 3.7% | ||
JNJ | US$144.02 | -1.1% | -10.3% | US$348.2b | US$174.28 | PE23.5x | E9.4% | 3.4% | ||
NOVO B | DKK 638.80 | 2.6% | -12.4% | DKK 2.8t | DKK 898.09 | PE29.8x | E13.1% | 1.5% | ||
LLY | US$778.07 | -2.0% | 26.6% | US$695.1b | US$984.05 | PE83.7x | E24.9% | 0.8% |